{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-006844","form_type":"8-K","ticker":"ACH","cik":"0000075252","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.155301+00:00","generated_at":"2026-05-22T06:03:39.447946+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Owens & Minor Q1 adj EPS $0.23, revenue $2.63B; reaffirms FY guide, active on P&HS sale","bullets":["Adjusted EPS $0.23 vs $0.19 YoY; GAAP net loss $(0.32) per share vs $(0.29).","Revenue $2.63B (+0.7% YoY); Patient Direct segment margin +173 bps.","Adjusted EBITDA $121.9M vs $116.3M YoY; full-year 2025 guidance reaffirmed.","Company actively engaged in potential sale of Products & Healthcare Services segment.","Integrating planned Rotech acquisition; monitoring tariff policy impacts."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-006844","json":"https://secwatch.observer/filing/0001558370-25-006844.json","markdown":"https://secwatch.observer/filing/0001558370-25-006844.md","text":"https://secwatch.observer/filing/0001558370-25-006844.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/75252/000155837025006844/0001558370-25-006844-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/75252/000155837025006844/omi-20250508x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T06:03:39.447946+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}